NCT04504942 2026-01-23
Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors
CytoDyn, Inc.
Phase 2 Completed
Clinical Trials
8 trialsNCT03905148 2026-01-07
Study of the Safety and Pharmacokinetics of BGB-283 (Lifirafenib) and PD-0325901 (Mirdametinib) in Participants With Advanced or Refractory Solid Tumors
BeOne Medicines
Phase 1 Completed
NCT05307874 2025-12-24
EVICTION-2
ImCheck Therapeutics
Phase 1/2 Completed
NCT05582850 2025-08-28
EPRAD
Domain Therapeutics SA
Phase 1 Completed
NCT02220556 2025-08-08
CTC-CEC-ADN
Institut Curie
Phase NA Completed
NCT03410121 2025-08-05
PACPAC-EPOC
Center Eugene Marquis
Phase NA Completed
NCT03990233 2025-06-26
A Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours
OSE Immunotherapeutics
Phase 1 Completed
NCT04899505 2025-05-16
ODORAJA
Institut Curie
Completed